483
Participants
Start Date
August 6, 2013
Primary Completion Date
September 25, 2014
Study Completion Date
November 12, 2019
Erenumab
Administered by study site staff once a month (QM) as a subcutaneous injection
Placebo
Administered by study site staff once a month (QM) as a subcutaneous injection
Erenumab PFS
Erenumab supplied in a single-use prefilled syringe for self-administration in the CHU substudy
Erenumab AI/Pen
Erenumab supplied in a single-use autoinjector/pen for self-administration in the CHU substudy
Research Site, Sandvika
Research Site, Hamar
Research Site, Glostrup Municipality
Research Site, Stavanger
Research Site, Ålesund
Research Site, Aarhus C
Research Site, Berlin
Research Site, Berlin
Research Site, Berlin
Research Site, Rochester
Research Site, Philadelphia
Research Site, Turku
Research Site, Hamburg
Research Site, Falls Church
Research Site, Virginia Beach
Research Site, Greensboro
Research Site, Raleigh
Research Site, Decatur
Research Site, Melbourne
Research Site, Tampere
Research Site, West Palm Beach
Research Site, Palm Beach Gardens
Research Site, Bradenton
Research Site, Nashville
Research Site, Louisville
Research Site, Lexington
Research Site, Bochum
Research Site, Essen
Research Site, Southfield
Research Site, Ann Arbor
Research Site, Kalamazoo
Research Site, Mikkeli
Research Site, Plymouth
Research Site, St Louis
Research Site, Springfield
Research Site, Wichita
Research Site, Dallas
Research Site, Dallas
Research Site, Arlington
Research Site, Houston
Research Site, Austin
Research Site, Salt Lake City
Research Site, Salt Lake City
Research Site, Phoenix
Research Site, Oulu
Research Site, Santa Monica
Research Site, Long Beach
Research Site, Sherman Oaks
Research Site, National City
Research Site, Spring Valley
Research Site, Newport Beach
Research Site, San Francisco
Research Site, Danbury
Research Site, Fairfield
Research Site, Stamford
Research Site, Watertown
Research Site, Worcester
Research Site, Toronto
Research Site, Montreal
Research Site, Helsinki
Research Site, Leipzig
Research Site, Falköping
Research Site, Lund
Research Site, Stockholm
Research Site, Stockholm
Research Site, Vällingby
Lead Sponsor
Amgen
INDUSTRY